Perceptive Advisors’s Nanobiotix NBTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-105,053
Closed -$376K 100
2025
Q1
$376K Sell
105,053
-161,040
-61% -$556K 0.01% 83
2024
Q4
$764K Sell
266,093
-288,973
-52% -$1.16M 0.02% 92
2024
Q3
$3.19M Hold
555,066
0.07% 88
2024
Q2
$2.78M Hold
555,066
0.07% 90
2024
Q1
$3.61M Hold
555,066
0.06% 96
2023
Q4
$4.04M Hold
555,066
0.09% 79
2023
Q3
$4.86M Sell
555,066
-504,734
-48% -$4.19M 0.16% 71
2023
Q2
$5.37M Hold
1,059,800
0.16% 75
2023
Q1
$3.74M Hold
1,059,800
0.11% 81
2022
Q4
$3.89M Hold
1,059,800
0.11% 75
2022
Q3
$3.75M Hold
1,059,800
0.11% 91
2022
Q2
$4.03M Hold
1,059,800
0.13% 81
2022
Q1
$7.88M Hold
1,059,800
0.16% 90
2021
Q4
$8.58M Hold
1,059,800
0.13% 103
2021
Q3
$12M Hold
1,059,800
0.17% 92
2021
Q2
$14.6M Hold
1,059,800
0.19% 97
2021
Q1
$15.9M Sell
1,059,800
-40,200
-4% -$691K 0.2% 89
2020
Q4
$18.1M Buy
+1,100,000
New +$19M 0.19% 91

Other funds holding NBTX

Perceptive Advisors's NBTX Position: Q2 2025 in Review

Perceptive Advisors sold out of Nanobiotix (NBTX) in Q2 2025, closing a stake of 105,053 shares — an estimated $376K sold.

Perceptive Advisors first reported a position in NBTX in Q4 2020 and held it in 18 quarters. The position peaked at $18.1M in Q4 2020. 10 funds tracked by Wall St. Rank hold NBTX as of Q2 2025.

  • Perceptive Advisors reported no remaining Nanobiotix position as of Q2 2025 after selling out during the quarter.
  • Perceptive Advisors sold 105,053 Nanobiotix shares in Q2 2025, an estimated $376K.
  • Perceptive Advisors first reported a position in Nanobiotix in Q4 2020 and held it in 18 quarters.
  • Perceptive Advisors's Nanobiotix position peaked at $18.1M in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2025.

Based on Perceptive Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.